Table 3.
Demographic, biochemical, and clinical characteristics of obese subjects with BMI < and ≥40 kg/m2 (obesity of degree 1–2 and degree 3, respectively), recruited in the study, subdivided into the two groups with or without metabolic syndrome, who underwent the 3-week BWRP.
| Obese Subjects with BMI < 40 kg/m2 | ||||
| Parameter | Without Metabolic Syndrome | With Metabolic Syndrome | ||
| Before | After | Before | After | |
| N. | 247 | - | 360 | - |
| Age (yr) | 47.0 ± 15.3 a | - | 53.6 ± 13.7 | - |
| BMI (kg/m2) | 37.4 ± 1.9 | 35.8 ± 1.9 b | 37.5 ± 1.9 | 35.9 ± 1.9 b |
| TOT-CHOL (mg/dL) | 193.1 ± 36.8 a | 169.2 ± 32.1 b | 199.4 ± 37.4 | 170.3 ± 35.0 b |
| HDL-CHOL (mg/dL) | 56.7 ± 11.6 a | 48.2 ± 10.0 b | 45.2 ± 10.9 | 40.4 ± 9.3 b |
| DBP (mmHg) | 74.2 ± 7.3 a | 73.3 ± 6.4 b | 76.2 ± 7.4 | 73.7 ± 6.1 b |
| SBP (mmHg) | 124.0 ± 12.7 a | 119.3 ± 9.1 b | 128.2 ± 12.7 | 120.8 ± 9.0 b |
| CHD score | 3.1 ± 5.4 a | 3.2 ± 5.5 | 8.3 ± 5.2 | 7.5 ± 5.8 b |
| FSS | 32.3 ± 11.9 a | 25.7 ± 11.0 b | 36.6 ± 12.8 | 28.5 ± 11.1 b |
| SCT (s) | 5.3 ± 1.6 a | 5.1 ± 1.6 b | 6.0 ± 1.9 | 5.7 ± 1.8 b |
| Obese Subjects with BMI ≥ 40 kg/m2 | ||||
| Parameter | Without Metabolic Syndrome | With Metabolic Syndrome | ||
| Before | After | Before | After | |
| N. | 479 | - | 836 | - |
| Age (yr) | 45.6 ± 15.3 a | - | 53.2 ± 12.1 | - |
| BMI (kg/m2) | 45.2 ± 4.6 a | 43.2 ± 4.4 b | 46.6 ± 6.0 | 44.5 ± 5.8 b |
| TOT-CHOL (mg/dL) | 198.3 ± 34.8 a | 167.4 ± 30.5 b | 197.4 ± 38.2 | 170.4 ± 35.0 b |
| HDL-CHOL (mg/dL) | 55.6 ± 12.6 a | 45.7 ± 10.5 b | 45.8 ± 11.6 | 39.5 ± 9.3 b |
| DBP (mmHg) | 77.2 ± 8.0 a | 74.1 ± 6.4 b | 78.2 ± 7.8 | 75.3 ± 6.7 b |
| SBP (mmHg) | 126.3 ± 14.4 a | 120.3 ± 8.9 b | 131.4 ± 13.8 | 122.8 ± 9.9 b |
| CHD score | 3.2 ± 5.5 a | 3.3 ± 5.6 | 8.5 ± 4.6 | 8.0 ± 4.9 b |
| FSS | 35.6 ± 13.0 a | 27.5 ± 11.8 b | 39.0 ± 12.9 | 30.4 ± 12.1 b |
| SCT (s) | 5.9 ± 1.9 a | 5.6 ± 1.8 b | 6.6 ± 1.9 | 6.2 ± 1.9 b |
Abbreviations: BMI, body mass index; TOT-CHOL, total cholesterol; HDL-chol, high-density lipoprotein cholesterol; DBP, diastolic blood pressure; SBP, systolic blood pressure; CHD, coronary heart disease; FSS, fatigue severity score; SCT, stair climbing test. a: p < 0.05 vs. group with metabolic syndrome; b: p < 0.05 vs. the corresponding group before BWRP.